- Home
- XWEL vs REVB Comparison
XWEL vs REVB Comparison
Compare XWEL & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XWEL
- REVB
- Stock Information
- Founded
- XWEL 2006
- REVB 2020
- Country
- XWEL United States
- REVB United States
- Employees
- XWEL N/A
- REVB N/A
- Industry
- XWEL Other Consumer Services
- REVB Biotechnology: Pharmaceutical Preparations
- Sector
- XWEL Consumer Discretionary
- REVB Health Care
- Exchange
- XWEL Nasdaq
- REVB Nasdaq
- Market Cap
- XWEL 4.7M
- REVB 3.8M
- IPO Year
- XWEL N/A
- REVB N/A
- Fundamental
- Price
- XWEL $1.13
- REVB $2.58
- Analyst Decision
- XWEL
- REVB
- Analyst Count
- XWEL 0
- REVB 0
- Target Price
- XWEL N/A
- REVB N/A
- AVG Volume (30 Days)
- XWEL 25.5K
- REVB 164.5K
- Earning Date
- XWEL 08-14-2025
- REVB 08-08-2025
- Dividend Yield
- XWEL N/A
- REVB N/A
- EPS Growth
- XWEL N/A
- REVB N/A
- EPS
- XWEL N/A
- REVB N/A
- Revenue
- XWEL $30,601,000.00
- REVB N/A
- Revenue This Year
- XWEL N/A
- REVB N/A
- Revenue Next Year
- XWEL N/A
- REVB N/A
- P/E Ratio
- XWEL N/A
- REVB N/A
- Revenue Growth
- XWEL N/A
- REVB N/A
- 52 Week Low
- XWEL $0.70
- REVB $2.11
- 52 Week High
- XWEL $2.09
- REVB $168.00
- Technical
- Relative Strength Index (RSI)
- XWEL 52.61
- REVB 45.75
- Support Level
- XWEL $1.09
- REVB $2.39
- Resistance Level
- XWEL $1.42
- REVB $2.70
- Average True Range (ATR)
- XWEL 0.07
- REVB 0.21
- MACD
- XWEL 0.00
- REVB 0.03
- Stochastic Oscillator
- XWEL 52.04
- REVB 51.61
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).